Biosplice submits NDA for lorecivivint, a potent
Author: Michael
Loyal’s lead drug for senior dogs moves closer
EyePoint Pharmaceuticals provided a corporate upd
Company aims to harness the therapeutic potentia
Regenxbio Inc.
Moves by a chipmaker and a pharma giant signal h
The peptide therapeutics market is projected to g
MBX Biosciences, Inc.
Dyno Therapeutics, a genetic technologies company
LifeVantage Corporation held its 2026 Global Kick